Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A 1.4 MB DOCX file authored by Hugo Geerts, last updated in April 2026, presents a quantitative systems pharmacology model for Alzheimer's Disease. The model accounted for 70% and 50% of the variance in observed plasma p-tau181 and Clinical Dementia Rating-Sum Of Boxes changes, respectively, across trials of seven amyloid antibodies. It provides antibody-specific normalized decreases in plasma p-tau181 and hypotheses on the impact of disease pathology and gender on functional outcomes.
The dataset is a DOCX document containing model descriptions and results, not a structured data table.